The NICE Reference Case Requirement: More Pain for What, if Any, Gain?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.4, 2004-01, pp. : 271-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Which antidepressants are the biggest culprits in weight gain?

Reactions Weekly, Vol. 1, Iss. 1322, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

What's going on with NICE guidance?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

What's NICE in new recommendations?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The NICE Reference Case Requirement: Implications for Drug Manufacturers and Health Systems

By Langley P.C.

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 267-271

Adis International

Access to resources Recommend Favorite

NICE Says No to Inhaled Insulin: What Lessons Should We Learn?

By Freemantle Nick

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 627-629

Adis International

Access to resources Recommend Favorite